FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / technology-transfer-agreement.docx
technology-transfer-agreement.docx · 1018-00006

Parties

Penterra Pharmaceuticals Corp
Hong Kong SA
Alkerra Manufacturing Inc

Dates

October 2, 2023
October 20, 2023
October 20, 2025
December 19, 2023
April 20, 2024
February 20, 2024
October 20, 2024
January 20, 2025
August 20, 2024
April 20, 2025

Amounts

$5,000.00
$18,000,000.00

Obligations

located at 5200 Meridian Parkway, Research Triangle Park, North Carolina 27713; WHEREAS, the License Agreement further requires Penterra to transfer its proprietary manufacturing process, analytical methods, and chemistry, manufacturing and controls documentation to Meridian's designated Asia-Pacific manufacturing facility or contract manufacturing organization to enable Meridian to independently manufacture PPC-4187 in the Licensed Territory following the expiration of the initial supply period; WHEREAS, the parties intend that such technology transfer shall be completed within twenty-four (24) months of the Effective Date (i
Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to them in the License Agreement
In addition to terms defined elsewhere in this Agreement, the following terms shall have the meanings set forth below: (a) "Acceptance Criteria" means the criteria set forth in Schedule 2 attached hereto that the Receiving Facility must satisfy to demonstrate successful completion of each Transfer Milestone, as further described in Article 4 of this Agreement
Unless the context otherwise requires, the rules of interpretation set forth in the License Agreement shall apply to this Agreement
The headings and captions of Articles, Sections, and Schedules are for convenience of reference only and shall not affect the interpretation of this Agreement
The words "include," "includes," and "including" shall be deemed to be followed by the phrase "without limitation